The 2026 Nobel Prize in Physiology or Medicine was awarded on October 5 to Karl Deisseroth, Peter Hegemann and Georg Nagel for developing optogenetics, a technique that lets scientists control selected nerve cells with light.
The method combines genetic engineering with light-sensitive proteins to activate or silence individual neurons in living brains. Hegemann and Nagel discovered channelrhodopsin, a light-responsive protein in single-celled algae, while Deisseroth adapted it for use in nerve cells. By shining blue light on modified cells, researchers can trigger electrical signals and observe how specific neural circuits affect behavior.
The technique helps scientists move beyond simply observing brain activity by testing cause and effect. It has become an important tool for studying memory, emotion, movement and disorders including depression and Parkinson’s disease. The Nobel committee said the discoveries created new opportunities for mapping how the brain produces feelings, behaviors and bodily functions.
The award recognizes foundational research rather than an approved treatment, though the findings could eventually inform new approaches to neurological and psychiatric illness.